PSIL vs MFUT

Comparison between ADVISORSHARES PSYCHEDELICS ETF (PSIL, ETF) and CAMBRIA CHESAPEAKE PURE TREND ETF (MFUT, ETF).

PSIL vs MFUT - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	PSIL(ETF)	MFUT(ETF)
Net Assets	$33M	$33M
Expense Ratio	1.00%	1.18%
Max Drawdown	92.97%	29.51%
Sharpe Ratio	1.23	1.80
5Y Beta	0.87	0.30
P/E Ratio	-2.81	N/A
Debt to Equity	39.16%	N/A
P/S Ratio	4.83	N/A
P/B Ratio	2.22	N/A

Net Assets

PSIL

$33M

Winner

MFUT

$33M

Expense Ratio

Winner

PSIL

1.00%

MFUT

1.18%

Max Drawdown

PSIL

92.97%

Winner

MFUT

29.51%

Sharpe Ratio

PSIL

1.23

Winner

MFUT

1.80

5Y Beta

PSIL

0.87

Winner

MFUT

0.30

P/E Ratio

PSIL

-2.81

MFUT

N/A

Debt to Equity

PSIL

39.16%

MFUT

N/A

P/S Ratio

PSIL

4.83

MFUT

N/A

P/B Ratio

PSIL

2.22

MFUT

N/A

PSIL vs MFUT - Holdings Comparison

PSIL and MFUT have 1 common holdings. Overlap is -21.43%

PSIL's top 25 holdings weight is 99.45%. MFUT's top 25 holdings weight is 396.89%.

Rank	PSIL	MFUT
#1	COMPASS PATHWAYS PLC ADR (CMPS) - 11.44%	CASH OFFSET (n/a) - 162.85%
#2	ATAIBECKLEY INC (ATAI) - 9.79%	FIRST AMERICAN GOVERNMENT OBLIGS X (FGXXX) - 37.95%
#3	DEFINIUM THERAPEUTICS INC ORDINARY SHARES (DFTX) - 8.40%	OTHER ASSETS AND LIABILITIES (n/a) - 36.20%
#4	RELMADA THERAPEUTICS INC (RLMD) - 7.99%	USD/CNH FWD 20260318 PURCHASED (n/a) - 21.34%
#5	NRX PHARMACEUTICALS INC ORDINARY SHARES (NRXP) - 7.63%	USD/INR FWD 20251217 PURCHASED (n/a) - 9.47%
#6	GH RESEARCH PLC (GHRS) - 6.08%	INR/USD FWD 20251217 PURCHASED (n/a) - 9.34%
#7	NEUROCRINE BIOSCIENCES INC (NBIX) - 4.80%	INR/USD FWD 20260318 PURCHASED (n/a) - 9.04%
#8	BRIGHT MINDS BIOSCIENCES INC ORDINARY SHARES (n/a) - 4.69%	SGD/USD FWD 20251217 PURCHASED (n/a) - 8.27%
#9	ALKERMES PLC (ALKS) - 4.14%	CNH/USD FWD 20251217 PURCHASED (n/a) - 7.49%
#10	ALTO NEUROSCIENCE INC (ANRO) - 3.73%	USD/CNH FWD 20251217 PURCHASED (n/a) - 7.46%
#11	ABBVIE INC (ABBV) - 3.73%	GOLD FUTURE FEB 26 (n/a) - 7.33%
#12	QUANTUM BIOPHARMA LTD ORDINARY SHARES CLASS B (SUB VOTING) (QNTM) - 3.65%	PHP/USD FWD 20251217 PURCHASED (n/a) - 6.74%
#13	HELUS PHARMA INC ORDINARY SHARES (n/a) - 3.61%	PHP/USD FWD 20260121 PURCHASED (n/a) - 6.73%
#14	NEUPHORIA THERAPEUTICS INC ORDINARY SHARES (NEUP) - 3.51%	MXN/USD FWD 20251217 PURCHASED (n/a) - 6.72%
#15	JOHNSON & JOHNSON (JNJ) - 3.45%	USD/PHP FWD 20251217 PURCHASED (n/a) - 6.70%
#16	SUPERNUS PHARMACEUTICALS INC (SUPN) - 3.35%	LIVE CATTLE FUTURE FEB 26 (n/a) - 6.65%
#17	NEURONETICS INC (STIM) - 2.23%	USD/MXN FWD 20251217 PURCHASED (n/a) - 6.46%
#18	PASITHEA THERAPEUTICS CORP (KTTA) - 1.52%	ILS/USD FWD 20251217 PURCHASED (n/a) - 6.11%
#19	PSYENCE BIOMEDICAL LTD (PBM) - 1.25%	USD/ILS FWD 20251217 PURCHASED (n/a) - 5.95%
#20	SILO PHARMA INC (SILO) - 1.18%	USD/MXN FWD 20260318 PURCHASED (n/a) - 5.95%
#21	OPTIMI HEALTH CORP (n/a) - 0.88%	USD/ILS FWD 20260318 PURCHASED (n/a) - 5.53%
#22	NUMINUS WELLNESS INC ORDINARY SHARES (NUMIF) - 0.82%	KRW/USD FWD 20251217 PURCHASED (n/a) - 5.30%
#23	VISTAGEN THERAPEUTICS INC (VTGN) - 0.71%	USD/BRL FWD 20251217 PURCHASED (n/a) - 3.81%
#24	IGC PHARMA INC (IGC) - 0.45%	USD/NOK FWD 20251217 PURCHASED (n/a) - 3.80%
#25	BLACKROCK TREASURY TRUST INSTL 62 (n/a) - 0.42%	NOK/USD FWD 20251217 PURCHASED (n/a) - 3.70%
Total Holdings	32	199